Briggs drugs in pregnancy and lactation 12th edition - A Reference Guide to Fetal and Neonatal Risk
A Reference Guide to Fetal and Neonatal Risk
Description détaillée : Briggs drugs in pregnancy and lactation 12th edition - A Reference Guide to Fetal and Neonatal Risk
Essential for ob/gyn physicians, primary care physicians, and any health care provider working with pregnant or postpartum women, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 12th Edition, puts must-know information at your fingertips in seconds.
What is the content of "Briggs Drugs in Pregnancy and Lactation 12th edition" ?
An easy A-to-Z format lists more than 1,400 of the most commonly prescribed drugs taken during pregnancy and lactation, with detailed monographs designed to provide the most essential information on possible effects on the mother, embryo, fetus, and nursing infant.
Each templated monograph includes:
- Generic US name (trade names in index)
- Risk factors
- Pharmacologic class
- Pregnancy and breastfeeding recommendations
- Pregnancy, fetal risk, and breastfeeding summaries
- Updated references
- NEW in the 12th Edition:
- 100 new drugs, with thorough updates of all existing drugs
- Subheadings with each review for faster reference
- List of cross-referenced combination drugs
- List of drugs contraindicated in breastfeeding women
- List of drugs contraindicated in pregnancy
- List of drugs that affect human development
- Quarterly updates, available online, to keep you at the forefront of the field
- Greatly improved eBook searchability
Enrich Your eBook Reading Experience
- Read directly on your preferred device(s), such as computer, tablet, or smartphone.
- Easily convert to audiobook, powering your content with natural language text-to-speech.
Who are the authors of "Briggs Drugs in Pregnancy and Lactation 12th edition" ?
Gerald G. Briggs is a Pharmacist Clinical Specialist (Obstetrics) for Perinatal Support Services, Memorial Care Center for Women, Miller Children’s Hospital, Long Beach Memorial Medical Center, California, USA. He currently serves as a member of the Best Practice Team for Women’s Health for Memorial Care, an organization of five hospitals.
He is a Clinical Professor at the University of California, San Francisco, and an Adjunct Professor at the University of Southern California, Los Angeles. As Co-Chair of the Research Committee, Organization of Teratology Information Specialists (OTIS), he oversees international studies evaluating the effects of specific drugs on the embryo and fetus. He also is a consultant to the Pregnatox Research Group at Georgetown University Medical Center. Briggs has authored or co-authored 41 papers in peer-reviewed journals and 12 book chapters, relating to drug therapy in pregnant or breastfeeding women and drug-induced developmental toxicity.
He is the senior author of Drugs in Pregnancy and Lactation, 12th edition, 2021, and writes a quarterly update for this book. He also writes a quarterly column on drugs in pregnancy and lactation for the International Medical News Group. He is a peer-reviewer for nine medical journals and serves on the editorial board of one journal. His current practice involves clinical research and drug therapy management of selected conditions for pregnant and postpartum women.
Roger K. Freeman
Craig V Towers : Maternal and Fetal Medicine, University of Tennessee Medical Center, Knoxville, TN, USA. Craig V Towers is an obstetrician-gynecologist in Knoxville, Tennessee and is affiliated with multiple hospitals in the area, including University of Tennessee Medical Center and MemorialCare Long Beach Medical Center. He received his medical degree from University of Kansas School of Medicine and has been in practice for more than 20 years.
Alicia B. Forinash
À PARAÎTRE OU DERNIÈRE PARUTION DANS LA MÊME CATÉGORIE :
- A paraître
Date de parution :
19 décembre 2022
Expédition sous 6 à 10 jours
Bénéficiez de la remise de 5% en choisissant le retrait en magasin
d'achats en France Métropolitaine
sous 14 jours ouvrés
Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email